Literature DB >> 19107348

Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.

Buelent Polat1, Iris Guenther, Juergen Wilbert, Joachim Goebel, Reinhart A Sweeney, Michael Flentje, Matthias Guckenberger.   

Abstract

PURPOSE: To evaluate intra-fractional uncertainties during intensity-modulated radiotherapy (IMRT) of prostate cancer. PATIENTS AND METHODS: During IMRT of 21 consecutive patients, kilovolt (kV) cone-beam computed tomography (CBCT) images were acquired prior to and immediately after treatment: a total of 252 treatment fractions with 504 CBCT studies were basis of this analysis. The prostate position in anterior-posterior (AP) direction was determined using contour matching; patient set-up based on the pelvic bony anatomy was evaluated using automatic image registration. Internal variability of the prostate position was the difference between absolute prostate and patient position errors. Intra-fractional changes of prostate position, patient position, rectal distension in AP direction and bladder volume were analyzed.
RESULTS: With a median treatment time of 16 min, intra-fractional drifts of the prostate were >5 mm in 12% of all fractions and a margin of 6 mm was calculated for compensation of this uncertainty. Mobility of the prostate was independent from the bony anatomy with poor correlation between absolute prostate motion and motion of the bony anatomy (R2=0.24). A systematic increase of bladder filling by 41 ccm on average was observed; however, these changes did not influence the prostate position. Small variations of the prostate position occurred independently from intra-fractional changes of the rectal distension; a weak correlation between large internal prostate motion and changes of the rectal volume was observed (R2=0.55).
CONCLUSION: Clinically significant intra-fractional changes of the prostate position were observed and margins of 6 mm were calculated for this intra-fractional uncertainty. Repeated or continuous verification of the prostate position may allow further margin reduction.

Entities:  

Mesh:

Year:  2008        PMID: 19107348     DOI: 10.1007/s00066-008-1875-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  40 in total

1.  Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.

Authors:  G O De Meerleer; L A Vakaet; W R De Gersem; C De Wagter; B De Naeyer; W De Neve
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-06-01       Impact factor: 7.038

Review 2.  [Image-guided radiotherapy by in-room CT-linear accelerator combination].

Authors:  R de Crevoisier; D Kuban; D Lefkopoulos
Journal:  Cancer Radiother       Date:  2006-09-07       Impact factor: 1.018

3.  Initial clinical experience with infrared-reflecting skin markers in the positioning of patients treated by conformal radiotherapy for prostate cancer.

Authors:  Guy Soete; Jan Van de Steene; Dirk Verellen; Vincent Vinh-Hung; Dirk Van den Berge; Dirk Michielsen; Frans Keuppens; Patricia De Roover; Guy Storme
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-01       Impact factor: 7.038

4.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

Authors:  Stephanie T H Peeters; Wilma D Heemsbergen; Peter C M Koper; Wim L J van Putten; Annerie Slot; Michel F H Dielwart; Johannes M G Bonfrer; Luca Incrocci; Joos V Lebesque
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

5.  Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes.

Authors:  Patrick A Kupelian; Vipul V Thakkar; Deepak Khuntia; Chandana A Reddy; Eric A Klein; Arul Mahadevan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

6.  Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI).

Authors:  Michel J Ghilezan; David A Jaffray; Jeffrey H Siewerdsen; Marcel Van Herk; Anil Shetty; Michael B Sharpe; Syed Zafar Jafri; Frank A Vicini; Richard C Matter; Donald S Brabbins; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

7.  Intrafraction prostate motion during IMRT for prostate cancer.

Authors:  Eugene Huang; Lei Dong; Anurag Chandra; Deborah A Kuban; Isaac I Rosen; Anissa Evans; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

8.  Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.

Authors:  Hassan Elsayed; Tobias Bölling; Christos Moustakis; Stefan-Bodo Müller; Patrick Schüller; Iris Ernst; Normann Willich; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2007-11       Impact factor: 3.621

Review 9.  Megavoltage cone-beam CT: system description and clinical applications.

Authors:  Olivier Morin; Amy Gillis; Josephine Chen; Michèle Aubin; M Kara Bucci; Mack Roach; Jean Pouliot
Journal:  Med Dosim       Date:  2006       Impact factor: 1.482

10.  Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?

Authors:  Matthias Guckenberger; Kurt Baier; Anne Richter; Dirk Vordermark; Michael Flentje
Journal:  Radiat Oncol       Date:  2008-01-11       Impact factor: 3.481

View more
  32 in total

1.  Numerical deconvolution to enhance sharpness and contrast of portal images for radiotherapy patient positioning verification.

Authors:  H K Looe; Y Uphoff; D Harder; B Poppe; K C Willborn
Journal:  Strahlenther Onkol       Date:  2012-01-12       Impact factor: 3.621

2.  Phase-specific cone beam computed tomography reduces reconstructed volume loss of moving phantom.

Authors:  H-L Chao; W-L Chen; C-C Hu; J-K Wu; C-J Wu; J C-H Cheng
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

3.  Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.

Authors:  Georgina Fröhlich; Péter Agoston; József Lövey; András Somogyi; János Fodor; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

4.  Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors:  Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

5.  Overestimation of low-dose radiation in intensity-modulated radiotherapy with sliding-window technique.

Authors:  Hilke Vorwerk; Daniela Wagner; Björn Seitz; Hans Christiansen; Hendrik A Wolff; Clemens F Hess
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

6.  Postoperative radiotherapy for advanced prostate cancer: improved local control translates into increased survival.

Authors:  Marie-Luise Sautter-Bihl; Felix Sedlmayer; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

7.  Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?

Authors:  G Eminowicz; C Dean; O Shoffren; N Macdougall; P Wells; R Muirhead
Journal:  Br J Radiol       Date:  2014-03-20       Impact factor: 3.039

8.  MRI assessment of cervical cancer for adaptive radiotherapy.

Authors:  Johannes C A Dimopoulos; Gertrude Schirl; Anja Baldinger; Thomas H Helbich; Richard Pötter
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

9.  Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results.

Authors:  Jürgen Wilbert; Matthias Guckenberger; Bülent Polat; Otto Sauer; Michael Vogele; Michael Flentje; Reinhart A Sweeney
Journal:  Radiat Oncol       Date:  2010-05-26       Impact factor: 3.481

10.  External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006: time trends, outcome, and risk stratification.

Authors:  Yasuo Yoshioka; Osamu Suzuki; Kana Kobayashi; Teruki Teshima; Yuji Yamada; Tadayuki Kotsuma; Masahiko Koizumi; Kazufumi Kagawa; Masashi Chatani; Shigetoshi Shimamoto; Eiichi Tanaka; Hideya Yamazaki; Takehiro Inoue
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.